Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121783) titled 'Application of [68Ga]DPI-4452 PET/CT in the diagnosis of clear cell renal cell carcinoma and monitoring therapeutic response to targeted-immunotherapy' on April 2.
Study Type: Diagnostic test
Study Design:
Sequential
Primary Sponsor: Chinese PLA General Hospital
Condition:
Clear cell renal cell carcinoma
Intervention:
Gold Standard:Histopathological results
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2025-11-30
Target Sample Size: Target condition:60;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=313033...